Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31127430 | 0.80 | LPL (0.30) | LPLLIPG | |
| SCHEMBL3678647 | 0.74 | EGFR (0.33) | LPLLIPG | |
| SCHEMBL24985353 | 0.74 | LPL (0.36) | LPLLIPG | |
| SCHEMBL30973580 | 0.72 | F2RL3 (0.34) | — | |
| SCHEMBL30973518 | 0.71 | — | — | |
| SCHEMBL21410690 | 0.71 | EGFR (0.36) | LPLLIPG | |
| SCHEMBL30973593 | 0.71 | ADORA2A (0.30) | — | |
| SCHEMBL30973447 | 0.71 | HTR2C (0.31) | — | |
| SCHEMBL4733734 | 0.70 | EGFR (0.31) | — | |
| SCHEMBL391335 | 0.70 | LPL (0.43) | LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642784-A1 | HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 | PTC Therapeutics, Inc. (US) | 2025-11-05 | — | — | EP | disclosed |
| WO-2024145623-A1 | HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 | PTC THERAPEUTICS, INC. (US) | 2024-07-04 | — | — | WO | disclosed |